These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 26527250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib.
    Liu D, Liu A, Peng J, Hu Y, Feng X.
    Eur J Med Res; 2015 Feb 04; 20(1):12. PubMed ID: 25649133
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions.
    Lee SH, Song IH, Noh R, Kang HY, Kim SB, Ko SY, Lee ES, Kim SH, Lee BS, Kim AN, Chae HB, Kim HS, Lee TH, Kang YW, Lee JD, Lee HY.
    BMC Cancer; 2015 Apr 08; 15():236. PubMed ID: 25885683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
    Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M, Sangiovanni A, Porta C, Gerken G, Marrero JA, Nadel A, Shan M, Moscovici M, Voliotis D, Llovet JM.
    J Hepatol; 2012 Oct 08; 57(4):821-9. PubMed ID: 22727733
    [Abstract] [Full Text] [Related]

  • 7. Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma.
    Elleuch N, Ennaifer R, Romdhane H, Cheikh M, Hefaiedh R, Bougassas W, Ben Nejma H, BelHadj N.
    Tunis Med; 2015 Jun 08; 93(6):350-2. PubMed ID: 26644095
    [Abstract] [Full Text] [Related]

  • 8. Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinoma.
    Kirstein MM, Schweitzer N, Schmidt S, Klöpper A, Ringe KI, Lehmann U, Manns MP, Wedemeyer H, Vogel A.
    Acta Gastroenterol Belg; 2014 Dec 08; 77(4):386-8. PubMed ID: 25682626
    [Abstract] [Full Text] [Related]

  • 9. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Liver Int; 2013 Jul 08; 33(6):950-7. PubMed ID: 23601249
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy.
    Park JG, Park SY, Lee HW.
    World J Gastroenterol; 2015 Feb 28; 21(8):2568-72. PubMed ID: 25741170
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.
    De Simone P, Crocetti L, Pezzati D, Bargellini I, Ghinolfi D, Carrai P, Leonardi G, Della Pina C, Cioni D, Pollina L, Campani D, Bartolozzi C, Lencioni R, Filipponi F.
    Transplant Proc; 2014 Feb 28; 46(1):241-4. PubMed ID: 24507059
    [Abstract] [Full Text] [Related]

  • 19. Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response.
    Zhang Y, Fan W, Zhu K, Lu L, Fu S, Huang J, Wang Y, Yang J, Huang Y, Yao W, Li J.
    Oncotarget; 2015 Sep 15; 6(27):24550-9. PubMed ID: 26093084
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.
    Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK.
    Clin Mol Hepatol; 2017 Jun 15; 23(2):128-137. PubMed ID: 28494528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.